BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 27871109)

  • 1. [Graves' Orbitopathy].
    Eckstein A; Esser J; Mattheis S; Berchner-Pfannschmidt U
    Klin Monbl Augenheilkd; 2016 Dec; 233(12):1385-1407. PubMed ID: 27871109
    [No Abstract]   [Full Text] [Related]  

  • 2. Practical Guidelines Management of Graves Ophthalmopathy.
    Subekti I; Soewondo P; Soebardi S; Darmowidjojo B; Harbuwono DS; Purnamasari D; Tarigan TJE; Wisnu W; Tahapary DL; Kurniawan F; Sidik M; Nusanti S; Dewiputri S; Suharko H; Suardana GG; Suroyo I; Wulani V; Siswoyo AD; Gondhowiardjo S; Kodrat H
    Acta Med Indones; 2019 Oct; 51(4):364-371. PubMed ID: 32041923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Drug therapy and radiotherapy in Graves' orbitopathy].
    Beisse F; Lagrèze WA; Schmucker M
    Ophthalmologe; 2011 May; 108(5):425-31. PubMed ID: 21590352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Graves' ophthalmopathy].
    Eckstein A; Dekowski D; Führer-Sakel D; Berchner-Pfannschmidt U; Esser J
    Ophthalmologe; 2016 Apr; 113(4):349-64; quiz 465-6. PubMed ID: 27059986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The evaluation and treatment of graves ophthalmopathy.
    Stan MN; Garrity JA; Bahn RS
    Med Clin North Am; 2012 Mar; 96(2):311-28. PubMed ID: 22443978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimal management of Graves orbitopathy: a multidisciplinary approach.
    Soeters MR; van Zeijl CJ; Boelen A; Kloos R; Saeed P; Vriesendorp TM; Mourits MP
    Neth J Med; 2011; 69(7):302-8. PubMed ID: 21934174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Update on endocrine orbitopathy].
    Ponto KA; Kahaly GJ; Pitz S
    Klin Monbl Augenheilkd; 2009 Feb; 226(2):R13-28; quiz R29-31. PubMed ID: 19206039
    [No Abstract]   [Full Text] [Related]  

  • 8. [Current management of endocrine orbitopathy].
    Ponto KA; Kahaly GJ
    Med Klin (Munich); 2008 Oct; 103(10):717-30; quiz 729-30. PubMed ID: 18936897
    [No Abstract]   [Full Text] [Related]  

  • 9. Evaluation and management of Graves' orbitopathy.
    Lee HB; Rodgers IR; Woog JJ
    Otolaryngol Clin North Am; 2006 Oct; 39(5):923-42, vi. PubMed ID: 16982255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Combined idiopathic orbital inflammation and Graves' orbitopathy].
    Ciechanowski PP; Töteberg-Harms M; Pangalu A; Chaloupka K
    Klin Monbl Augenheilkd; 2012 Apr; 229(4):466-7. PubMed ID: 22496035
    [No Abstract]   [Full Text] [Related]  

  • 11. Graves' orbitopathy: a multidisciplinary approach.
    Limone PP; Mellano M; Ruo Redda MG; Macera A; Ferrero V; Sellari Franceschini S; Deandrea M
    Q J Nucl Med Mol Imaging; 2021 Jun; 65(2):157-171. PubMed ID: 33634673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined immunosuppressants and less steroids in active graves' orbitopathy?
    Salvi M; Covelli D
    Clin Endocrinol (Oxf); 2019 Apr; 90(4):525-527. PubMed ID: 30549306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Viral conjunctivitis interfering with the clinical activity score and management of thyroid ophthalmopathy.
    Boboridis KG; Konstas AG; Krassas GE; Georgiadis NS
    Orbit; 2006 Mar; 25(1):27-9. PubMed ID: 16527772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Management of Graves' orbitopathy. Comments on the EUGOGO consensus statement].
    Bednarczuk T; Bar-Andziak E; Hubalewska-Dydejczyk A; Waligórska A; Górska M; Myśliwiec J; Jarzab B; Karczmarzyk R; Zawadzka A; Garmol D; Kecik D; Królicki L; Plazińska MT; Krzeski A; Krzyzanowska-Swiniarska B; Lewiński A; Milewicz A; Daroszewski J; Placzkiewicz-Jankowska E; Pilarska K; Skórski M; Wiechno W; Sowiński J; Syrenicz A; Szafilk J; Wanyura H; Zgliczński W; Jastrzebska H; Nauman J
    Endokrynol Pol; 2009; 60(4):312-30. PubMed ID: 19753546
    [No Abstract]   [Full Text] [Related]  

  • 15. Graves' orbitopathy: Diagnosis and treatment.
    Drui D; Du Pasquier Fediaevski L; Vignal Clermont C; Daumerie C
    Ann Endocrinol (Paris); 2018 Dec; 79(6):656-664. PubMed ID: 30177259
    [No Abstract]   [Full Text] [Related]  

  • 16. Thyroid Orbitopathy.
    Wang Y; Tooley AA; Mehta VJ; Garrity JA; Harrison AR; Mettu P
    Int Ophthalmol Clin; 2018; 58(2):137-179. PubMed ID: 29517649
    [No Abstract]   [Full Text] [Related]  

  • 17. Graves' ophthalmopathy treated with protracted hypofractionated low-dose adaptive radiotherapy: case report and review of the literature.
    Guler OC; Onal C; Arslan G
    Wien Klin Wochenschr; 2016 Apr; 128(7-8):299-303. PubMed ID: 26466836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of patients with Graves' orbitopathy: initial assessment, management outside specialized centres and referral pathways.
    Orgiazzi J
    Clin Endocrinol (Oxf); 2016 May; 84(5):662-3. PubMed ID: 26866718
    [No Abstract]   [Full Text] [Related]  

  • 19. [Graves' orbitopathy: diagnosis, epidemiology and treatments].
    Lun AY; Le Bras M; Scharbarg E; Morcel P; Hadjadj S; Lebranchu P; Drui D
    Rev Med Interne; 2022 Apr; 43(4):242-251. PubMed ID: 35221112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Graves' ophthalmopathy].
    Hiromatsu Y
    Nihon Rinsho; 2006 May; Suppl 1():307-10. PubMed ID: 16776151
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.